Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Xiaojiao Sun
Introduction
Xiaojiao Sun is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with potential therapeutic applications. His work focuses on innovative solutions to combat various health challenges, including cancer.
Latest Patents
Xiaojiao Sun holds a patent for an indazole hydrazide compound and its applications. This compound, represented in formula (I), features R selected from substituted alkyl, substituted alkenyl, and substituted phenyl. The substituents in the substituted alkyl and substituted alkenyl include phenyl and/or substituted phenyl, while R′ is selected from H and alkyl. Compared to prior art, this indole hydrazide compound serves as an integrin avβ3 receptor antagonist. It demonstrates significant anti-prostate cancer activity and effectively inhibits enzalutamide-resistant cell lines. Additionally, the compound exhibits notable anti-tumor angiogenesis activity, making it a candidate for the preparation of anti-tumor angiogenesis drugs.
Career Highlights
Xiaojiao Sun is affiliated with Beijing Baheal Chengchuang Pharmaceutical Research and Development Co., Ltd. His role in this company allows him to further his research and development efforts in the pharmaceutical industry. His innovative work has the potential to lead to breakthroughs in cancer treatment and other medical applications.
Collaborations
Xiaojiao Sun collaborates with esteemed colleagues, including Yimin Cui and Xiaocong Pang. These partnerships enhance the research environment and contribute to the advancement of their collective goals in pharmaceutical innovation.
Conclusion
Xiaojiao Sun's contributions to the field of pharmaceuticals, particularly through his patented indazole hydrazide compound, highlight his role as an influential inventor. His work not only addresses critical health issues but also paves the way for future advancements in cancer treatment.